Solid Cancer

Oncology

16 drugs in development·5 companies·1 clinical trial

Drug Pipeline by Phase

Phase 2(3)

Phase 1(11)

Drug	Company
5-FU	AbCellera Biologics Inc. (ABCL)
apg-2449	ASCENTAGE PHARMA GROUP INTERNATIONAL (AAPG)
Cetuximab	AbCellera Biologics Inc. (ABCL)
Etoposide	AbCellera Biologics Inc. (ABCL)
GRT-C903/GRT-R904	Filana Therapeutics Inc. (FLNA)
GRT-C903/GRT-R904	Twist Bioscience Corp (TWST)
HCB101	AbCellera Biologics Inc. (ABCL)
Leucovorin	AbCellera Biologics Inc. (ABCL)
Pertuzumab	AbCellera Biologics Inc. (ABCL)
Ramucirumab	AbCellera Biologics Inc. (ABCL)
Toripalimab	AbCellera Biologics Inc. (ABCL)

Phase 1/Phase 2(2)

Drug	Company
BNT329	BioNTech SE (BNTX)
CA19-9-targeting monoclonal antibody	BioNTech SE (BNTX)

BioSniper tracks 16 drugs in development for Solid Cancer across 5 companies.

There are 1 clinical trial targeting Solid Cancer tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.